The 4th General Assembly held on September 26–27 in Florence, Italy, helped to foster the collaboration of HARMONY’s leaders, Partners, Associated Members and Patient Clusters. The program celebrated the success of HARMONY at its mid-point and used innovative ‘research-a-thons’ to kick-start HARMONY’s second wave of research projects across seven Hematologic Malignancies (HMs). This edition of the annual meeting was hosted by HARMONY Partner Menarini.
During the ‘research-a-thons’, participants were split into groups and allocated a specific HM to focus on. Their goal was to identify unmet research needs, determine what parameters needed to be evaluated, define the analytical techniques to be used and define new research topics in collaboration with multidisciplinary experts. Involvement of HARMONY’s patient groups, including Acute Leukemia Advocates Network, CLL Advocates Network, Lymphoma Coalition, International MDS Alliance, Myeloma Patients Europe and Childhood Cancer International ensured the patient perspective was reflected in every proposal.
New key research questions were then presented during the General Assembly in order to gain consensus and endorsement from HARMONY Partners and Associated Members. Examples of proposed research topics include:
The next step will be to translate these research questions into new HARMONY research projects, which we hope to launch in the first half of 2020.
In addition to our hands-on ‘research-a-thons’, several plenary presentations and panel discussions took place. These delivered key progress updates on HARMONY’s ongoing research efforts and gave attendees the opportunity to learn more about the value of HARMONY from experts in the field.
View our 'Results' page to see the scientific posters presented for each of the 7 HMs > (select scientific publications)
HARMONY is gaining increasing recognition in Italy. Click here to read about its developments
Stay up to date with our meetings page for more information on the next General Assembly and other events that HARMONY will be leading and attending.
Receive the latest news. Click here to subscribe!